Price supervisor Stefan Meierhans has demanded that parliament vote in favour of a proposal to introduce a reference price system, which he says could save CHF400 million ($437 million) a year.
The watchdog compared the prices of 20 patent-expired active ingredients with 15 reference countries. It found the average cost of generic drugs to be 165% higher in Switzerland – and 64% more expensive for patented drugs.
It costs five times more to treat a patient with the same drug in Switzerland than in the least expensive countries of Sweden, Denmark and Britain, said Meierhans in a newsletter published on Thursday.
In May, Santésuisse and Interpharma, the umbrella organisations for Swiss insurers and pharmaceutical research companies, also criticised the high price of medicines in Switzerland.
While their report acknowledged the impact of currency exchange rates on the comparative prices, it also called on lawmakers to introduce a reference price system.
More than 20 European countries already have such a system in place that bases insurance reimbursement payments for each active ingredient on the price of the cheapest available generic.
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Ex-sect member sentenced in Zurich for sexual abuse
This content was published on
Zurich District Court has sentenced a former member of the globally active sect "Children of God" to a partial prison sentence.
SNB chairman does not rule out slowdown in Swiss growth
This content was published on
Martin Schlegel, chairman of the Swiss National Bank (SNB), does not rule out a weakening of the Swiss economy in light of the tariff dispute.
Swiss NGOs abroad to receive 10% less federal funding
This content was published on
In 2025 and 2026, Swiss NGOs will have 10% less federal funding available for international cooperation than in the previous two-year period.
Swiss parties spent less than CHF1 million on February green vote
This content was published on
Swiss political parties spent CHF 700,000 ($840,000) on campaigns in the run-up to the overwhelmingly defeated vote on February 9, according to the Swiss Federal Audit Office.
This content was published on
Swisswool, the largest Swiss wool processor, is not accepting any wool for the first time this spring. For many sheep farmers, the only option is to get rid of the wool.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland remains high price island for drugs
This content was published on
The price of medical drugs in Switzerland remains higher than in other major European markets, especially for generic drugs.
This content was published on
Helsana has also compiled a blacklist of expensive Swiss clinics, with the aim of rewarding clients who stay away from them. Cross-border operations are the latest money-saving strategy from Swiss insurers, eager to put the brakes on ever-increasing healthcare costs. Health costs in Switzerland increased in 2003 by more than four per cent to almost…
This content was published on
Swiss health insurance premiums are to go up again in 2021, but at 0.5% the average hike is milder than the norm over the past decades.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.